Motor Neuron Disease

• 

  Subject Areas on Research

  • "ALS reversals": demographics, disease characteristics, treatments, and co-morbidities. 
  • A gene for autosomal dominant juvenile amyotrophic lateral sclerosis (ALS4) localizes to a 500-kb interval on chromosome 9q34. 
  • A novel antineuronal antibody in a motor neuron syndrome associated with breast cancer. 
  • Amyotrophic lateral sclerosis: an emerging era of collaborative gene discovery. 
  • Apolipoprotein E and neuromuscular disease: a critical review of the literature. 
  • Atypical parkinsonism and motor neuron syndrome in a Biosphere 2 participant: a possible complication of chronic hypoxia and carbon monoxide toxicity? 
  • Correspondence regarding: TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010:69;918-29. 
  • Creatine for amyotrophic lateral sclerosis/motor neuron disease. 
  • Creatine for amyotrophic lateral sclerosis/motor neuron disease. 
  • Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis. 
  • Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. 
  • Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation. 
  • Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers. 
  • Macroglossia, Motor Neuron Pathology, and Airway Malacia Contribute to Respiratory Insufficiency in Pompe Disease: A Commentary on Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases. 
  • Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. 
  • Motor variant of chronic inflammatory demyelinating polyneuropathy in a child. 
  • Multifocal motor neuropathy: 30 years from onset to diagnosis. 
  • Multivariate discriminant analysis of the electromyographic interference pattern: statistical approach to discrimination among controls, myopathies and neuropathies. 
  • Myotendinous lengthening of the elbow flexor muscles to improve active motion in patients with elbow spasticity following brain injury. 
  • Neuromuscular ultrasound in polyneuropathies and motor neuron disease. 
  • Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. 
  • PLEKHG5 deficiency leads to an intermediate form of autosomal-recessive Charcot-Marie-Tooth disease. 
  • Problems in Comparing Jitter Values Obtained with Voluntary Activation and Electrical Stimulation. 
  • Senataxin, A Novel Helicase at the Interface of RNA Transcriptome Regulation and Neurobiology: From Normal Function to Pathological Roles in Motor Neuron Disease and Cerebellar Degeneration. 
  • Senataxin, the yeast Sen1p orthologue: characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease. 
  • The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration. 
• 

  Keywords of People

  • Cortes, Constanza J, Adjunct Assistant Professor in the Department of Neurology, Duke Institute for Brain Sciences